Oberursel, Germany

Wolfgang Moller


Average Co-Inventor Count = 3.1

ph-index = 9

Forward Citations = 243(Granted Patents)


Location History:

  • Oberursel/Ts., DE (1991)
  • Oberusel, DE (1996)
  • Oberursel, DE (1990 - 1999)

Company Filing History:


Years Active: 1990-1999

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Wolfgang Moller: Innovator in Immunoglobulin Therapies

Introduction

Wolfgang Moller is a distinguished inventor based in Oberursel, Germany. He has made significant contributions to the field of immunology, particularly in the development of oral immunoglobulin therapies. With a total of 12 patents to his name, Moller has been at the forefront of innovative treatments for complex medical conditions.

Latest Patents

Among his latest patents, Moller has developed a method for the oral administration of immunoglobulin preparations aimed at treating heavy therapy-refractory pain conditions in patients. This invention focuses on utilizing immunoglobulins derived from plasma, colostral milk, milk, eggs, or cell cultures. Another notable patent involves the use of bovine colostral milk as a protective preparation for liver function disturbances in liver diseases. This invention is particularly aimed at preventing sequelae such as portal encephalopathy.

Career Highlights

Moller has worked with Biotest Pharma GmbH, where he has contributed to various research and development projects. His work has been instrumental in advancing therapeutic options for patients suffering from severe medical conditions.

Collaborations

Moller has collaborated with notable professionals in his field, including Wolfgang Stephan and Michael Kraus. These partnerships have further enhanced his research and innovation efforts.

Conclusion

Wolfgang Moller is a prominent figure in the field of immunology, with a focus on developing innovative therapies through his patents. His work continues to impact the medical community positively, providing new avenues for treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…